ACR Recommendations for Hydroxychloroquine Management During the COVID-19 Pandemic
The American College of Rheumatology released guiding principles for the allocation, use, and management of hydroxychloroquine during the COVID-19 pandemic.
Systemic Lupus Erythematosus
SYSTEMIC LUPUS ERYTHEMATOSUS
-
-
Voclosporin Improves Renal Outcomes in Active Lupus Nephritis
Patients with active lupus nephritis who received voclosporin experienced a superior renal response as patients receiving standard of care. -
Increased Lupus Flare Frequency Associated With Worsened Patient Outcomes
Researchers evaluated the relationship between lupus flare frequency and patient outcomes and economic burden. -
Development of Damage Strongly Associated With Increased Mortality in SLE
Researchers conducted an analysis of factors affecting damage development in patients with systemic lupus erythematosus. -
Managing Dental and Orofacial Manifestations of Systemic Lupus Erythematosus
Researchers have addressed the diagnosis and management of dental and orofacial manifestations in patients with systemic lupus erythematosus, as no guidelines are currently available. -
A Vision for Lupus Develops Calls to Action to Improve Quality of Lupus Care
Patricia Cagnoli, MD, discusses the current gaps in lupus care and A Vision for Lupus initiative that aims to raise awareness and improve access to healthcare for patients with lupus. -
Adherence to Antimalarial Therapy Reduces Risk for Type 2 Diabetes in SLE
Adherence to antimalarial therapy can provide a protective effect against the development of type 2 diabetes in patients with systemic lupus erythematosus. -
Increased S aureus Colonization in Skin Lesions Among Patients With Lupus
Patients with systemic lupus erythematosus (SLE) have increased colonization with Staphylococcus aureus in cutaneous lupus erythematosus lesions. -
Renal Arteriosclerosis Common But Underreported in Lupus Nephritis
Researchers examined the burden of renal arteriosclerosis in lupus nephritis (LN), and they also assessed whether arteriosclerosis was underreported in LN biopsies. -
Chronic Damage Not Affected by Pregnancy in Systemic Lupus Erythematosus
Researchers evaluated the chronic damage associated with pregnancies before and after the diagnosis of systemic lupus erythematosus.
LATEST NEWS
Severe Illness Reported With Nonpharmaceutical Chloroquine Misuse for COVID-19 Prevention
The product that sickened the couple was in powder form and was labeled “for Ornamental Fish Use Only.”
Shortages Seen for Drugs That Show Promise Against COVID-19
Strong demand for medications that show promise as treatments for COVID-19 have led to shortages of those drugs in the United States.
Adverse Outcomes After Percutaneous Coronary Intervention More Prevalent in SSc, SLE
Patients with systemic sclerosis and systemic lupus erythematosus were found to be at increased odds of adverse clinical outcomes and bleeding, respectively, after percutaneous coronary intervention.
Anti-Carbamylated Protein Antibodies Linked to SLE Disease Activity
Researchers evaluated levels of serum anti-carbamylated protein antibodies and assessed their clinical value in systemic lupus erythematosus.
Neuropsychiatric Events Most Frequently Occur at SLE Diagnosis
Researchers examined the association between neuropsychiatric events and health-related quality of life in a cohort of patients with systemic lupus erythematosus.
Visual Analog Scale Assessments Can Reliably Assess Disease Severity in SLE
Researchers compared the performance of 2 visual analog scale-based assessments, SSPGA and LFA-REAL, with outcome measures from other lupus trials.
Renal Arteriosclerosis Develops Prematurely in Lupus Nephritis
A study found that renal arteriosclerosis develops 2 decades earlier in patients with lupus nephritis compared with healthy age-matched controls.
High Genetic Risk Score Associated With Organ Damage, Renal Dysfunction, and All-Cause Mortality in SLE
The study evaluated the association between high genetic disease risk and disease severity in patients with systemic lupus erythematosus.
Peripheral Nervous System Disease Has Significant Negative Effect on Quality of Life in SLE
Peripheral nervous system (PNS) disease is a component of systemic lupus erythematosus (SLE) disease activity and has a significant negative impact on health-related quality of life.
Antimalarial Drugs May Reduce Polyautoimmunity in Systemic Lupus Erythematosus
Researchers evaluated the frequency of polyautoimmunity and its associated factors in a large retrospective cohort of patients with systemic lupus erythematosus.
Want to read more?
Please login or register first to view this content.
Next post in Systemic Lupus Erythematosus
